Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-02-25

EMA Authorised: Tadalafil Mylan (tadalafil) — Mylan Pharmaceuticals Limited

View source ↗

Summary

The European Medicines Agency authorised Tadalafil Mylan (tadalafil) by Mylan Pharmaceuticals Limited for erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tadalafil Mylan (tadalafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Mylan Pharmaceuticals Limited. Decision date: 24/02/2025